Bought at £1.18.

Looking to expand my holdings in pharma. TILS looks to be an exciting company with multiple projects in the pipeline. I also like the look of the Covid product they are developing. This would allow the inhalation of drugs to help to better alleviate the uncontrolled immune response in the lungs of severe patients.

13 July 2020